These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29644943)

  • 1. Reduced Clostridium difficile Tests and Laboratory-Identified Events With a Computerized Clinical Decision Support Tool and Financial Incentive.
    Madden GR; German Mesner I; Cox HL; Mathers AJ; Lyman JA; Sifri CD; Enfield KB
    Infect Control Hosp Epidemiol; 2018 Jun; 39(6):737-740. PubMed ID: 29644943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost Analysis of Computerized Clinical Decision Support and Trainee Financial Incentive for Clostridioides difficile Testing.
    Madden GR; Cox HL; Poulter MD; Lyman JA; Enfield KB; Sifri CD
    Infect Control Hosp Epidemiol; 2019 Feb; 40(2):242-244. PubMed ID: 30466495
    [No Abstract]   [Full Text] [Related]  

  • 3. Reducing Clostridium difficile Colitis Rates Via Cost-Saving Diagnostic Stewardship.
    Yen C; Holtom P; Butler-Wu SM; Wald-Dickler N; Shulman I; Spellberg B
    Infect Control Hosp Epidemiol; 2018 Jun; 39(6):734-736. PubMed ID: 29611494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of a Computerized Clinical Decision Support Tool on Inappropriate Clostridium difficile Testing.
    White DR; Hamilton KW; Pegues DA; Hanish A; Umscheid CA
    Infect Control Hosp Epidemiol; 2017 Oct; 38(10):1204-1208. PubMed ID: 28760168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Asymptomatic Clostridium difficile Among Bone Marrow Transplant Patients: A Mixed-Methods Study of Intervention Effectiveness and Feasibility.
    Barker AK; Krasity B; Musuuza J; Safdar N
    Infect Control Hosp Epidemiol; 2018 Feb; 39(2):177-185. PubMed ID: 29366434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of Risk-Adjustment by Test Method for C. difficile Laboratory-Identified Event Reporting.
    Marra AR; Edmond MB; Ford BA; Herwaldt LA; Algwizani AR; Diekema DJ
    Infect Control Hosp Epidemiol; 2017 Jan; 38(1):109-111. PubMed ID: 27745553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Successful Strategy to Decrease Hospital-Onset Clostridium difficile.
    Bruno-Murtha LA; Osgood RA; Alexandre CE
    Infect Control Hosp Epidemiol; 2018 Feb; 39(2):234-236. PubMed ID: 29301591
    [No Abstract]   [Full Text] [Related]  

  • 8. Clostridium difficile: trend in an Italian Tertiary Care Hospital during fifteen years, 2002-2016.
    Masucci L; Nicolotti N; Graffeo R; Tamburrano A; Archibusacci CM; Nagel D; Quaranta G; Eisendle K; Primus S; Romano L; Mazzella P; Posteraro B; Cammarota G; Sanguinetti M
    Minerva Med; 2019 Apr; 110(2):168-171. PubMed ID: 30821431
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of Computerized Clinical Decision Support for Diagnostic Stewardship in Clostridioides difficile testing: an Academic Hospital Quasi-Experimental Study.
    Friedland AE; Brown S; Glick DR; Lusby MC; Lemkin D; Leekha S
    J Gen Intern Med; 2019 Jan; 34(1):31-32. PubMed ID: 30218259
    [No Abstract]   [Full Text] [Related]  

  • 10. Reduced Clostridioides difficile Tests Among Solid Organ Transplant Recipients Through a Diagnostic Stewardship Bundled Intervention.
    Madden GR; Sifri CD
    Ann Transplant; 2019 May; 24():304-311. PubMed ID: 31133632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing testing for Clostridium difficile infection: A quality improvement project.
    Sperling K; Priddy A; Suntharam N; Feuerhake T
    Am J Infect Control; 2019 Mar; 47(3):340-342. PubMed ID: 30420098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The never-ending struggle with laboratory testing for Clostridium difficile infection.
    Polage CR; Turkiewicz JV; Cohen SH
    J Comp Eff Res; 2016 Mar; 5(2):113-6. PubMed ID: 26930504
    [No Abstract]   [Full Text] [Related]  

  • 13. Clostridium difficile Screening for Colonization During an Outbreak Setting.
    Linsenmeyer K; O'Brien W; Brecher SM; Strymish J; Rochman A; Itani K; Gupta K
    Clin Infect Dis; 2018 Nov; 67(12):1912-1914. PubMed ID: 29846539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of toxigenic Clostridium difficile polymerase chain reaction testing on the clinical microbiology laboratory and inpatient epidemiology.
    Napierala M; Munson E; Skonieczny P; Rodriguez S; Riederer N; Land G; Luzinski M; Block D; Hryciuk JE
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):534-8. PubMed ID: 23731555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing diagnostic testing for Clostridium difficile: The perceptions of physicians and nurses on when to order testing for C difficile.
    Blakney R; Yanke E; Fink C; Wigton R; Safdar N
    Am J Infect Control; 2015 Aug; 43(8):889-91. PubMed ID: 25957816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comprehensive Study of Costs Associated With Recurrent Clostridium difficile Infection.
    Rodrigues R; Barber GE; Ananthakrishnan AN
    Infect Control Hosp Epidemiol; 2017 Feb; 38(2):196-202. PubMed ID: 27817758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of fixed and variable hospital costs due to Clostridium difficile infection: institutional incentives and directions for future research.
    Ryan P; Skally M; Duffy F; Farrelly M; Gaughan L; Flood P; McFadden E; Fitzpatrick F
    J Hosp Infect; 2017 Apr; 95(4):415-420. PubMed ID: 28320542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study.
    Barbut F; Corthier G; Charpak Y; Cerf M; Monteil H; Fosse T; Trévoux A; De Barbeyrac B; Boussougant Y; Tigaud S; Tytgat F; Sédallian A; Duborgel S; Collignon A; Le Guern ME; Bernasconi P; Petit JC
    Arch Intern Med; 1996 Jul; 156(13):1449-54. PubMed ID: 8678714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reductions in Clostridium difficile Infection (CDI) Rates Using Real-Time Automated Clinical Criteria Verification to Enforce Appropriate Testing.
    Quan KA; Yim J; Merrill D; Khusbu U; Madey K; Dickey L; Dangodara AA; Rudkin SE; O'Brien M; Thompson D; Parekh N; Albers CG; Wilson WC; Thrupp L; Bittencourt CE; Huang SS; Gohil SK
    Infect Control Hosp Epidemiol; 2018 May; 39(5):625-627. PubMed ID: 29552992
    [No Abstract]   [Full Text] [Related]  

  • 20. Clostridium difficile--a common and costly colitis.
    Kofsky P; Rosen L; Reed J; Tolmie M; Ufberg D
    Dis Colon Rectum; 1991 Mar; 34(3):244-8. PubMed ID: 1999131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.